Clinical Application of Korean Version of the International Classification of Headache Disorders, 3rd Edition, Beta Version.
- Author:
Heui Soo MOON
1
;
Kwang Yeol PARK
;
Soo Jin CHO
Author Information
1. Department of Neurology, Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Diagnosis;
Classification;
Headache disorders;
Migraine
- MeSH:
Classification*;
Cluster Headache;
Consensus;
Diagnosis;
Facial Pain;
Female;
Headache;
Headache Disorders*;
Headache Disorders, Primary;
Headache Disorders, Secondary;
Humans;
Migraine Disorders;
Neuroimaging;
Surveys and Questionnaires;
Research Personnel;
Tension-Type Headache
- From:Journal of the Korean Neurological Association
2014;32(3):163-167
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: The International Classification of Headache Disorders, an essential tool in the diagnosis of headache disorders, has been revised as its 3rd edition, beta (ICHD-IIIbeta). The clinical application in practice is needed to test the feasibility and usefulness of the Korean version of ICHD-IIIbeta. METHODS: Neurologists enrolled consecutive first-visit headache patients from February to March 2014. The classification of headache disorder was done by each investigator according to ICHD-IIIbeta based on the initial structured questionnaire, clinical evaluation, and neuroimaging studies, if needed. A consensus meeting dealt with the cases that were difficult to diagnose. The feasibility and usefulness of this version was assessed by the proportion of unclassified headache disorders using ICHD-IIIbeta compared to the previous version. RESULTS: A total of 207 patients were enrolled: the mean age was 41 years (16-87 years) and women constituted 63.3%. Primary headache disorders were diagnosed in 167 patients (80.7%): 82 migraines, 37 tension-type headaches, 3 cluster headaches, and 45 other primary headache disorders. Thirty-five patients (16.9%) had secondary headache disorders or painful cranial neuropathies/other facial pain and 5 patients (2.4%) could not be classified by ICHD-IIIbeta. The diagnoses differed as compared to the previous version in 32 patients (15.5%): 14.5% differed due to the mitigation of the previous strict criteria and 1% differed due to the introduction of a new diagnostic category. CONCLUSIONS: Classifications by ICHD-IIIbeta are possible in more than 97% of the first-visit headache patients and ICHD-IIIbeta has proved to be more useful than its previous version.
